课题基金 / 基金详情

Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia.

Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia.
患有或不患有痴呆症的老年人小血管疾病的多模态 MRI 生物标志物。
批准号:
9272127
负责人:
Konstantinos Arfanakis
金额:
$111.19万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2018-07-31

项目摘要

项目成果

Konstantinos Arfanakis的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Small vessel disease (SVD) pathologies are very common in the brains of older persons and are related to decline in cognitive abilities, MCI, and dementia. SVD pathologies include three common vessel diseases and an array of related tissue injuries. SVD pathologies may cause dementia on their own but more commonly coexist with Alzheimer's disease (AD) and other age-related pathologies where they lower the threshold for dementia. Effective participant selection into trials, and prevention and treatment would greatly benefit from having in-vivo biomarkers of this pathology. Current biomarkers are limited by lack of specificity for SVD (vs. AD) pathology and lack of pathologic validation. We propose to overcome these obstacles by (1) further developing specific ex-vivo MR imaging features of SVD pathologies after controlling for AD and other pathologies, in the brains of persons with and without dementia; (2) training a classifier using machine learning and multimodal MRI, and testing the classifier in persons without dementia, and whether it is related to cognitive status proximate to death; (3) translating the classifier into an in-vivo biomarker which can be investigated in relation to vascular risk factors and cognition, MCI, and dementia; and (4) validating the biomarker in a separate cohort (ADNI) and by autopsy confirmation of SVD pathologies in a large group of older persons followed longitudinally with MRI who agree to autopsy at death. Finally we propose to (5) share data, expertise and biomarker strategies within the UH2/UH3 consortium and cross-validate selected biomarkers in older persons followed longitudinally with cognitive testing, blood draws and brain autopsy at the time of death. We propose to leverage the resources of two longitudinal clinical-imaging-pathology cohorts, the Rush Memory and Aging Project (MAP) (R01AG017917) and Religious Orders Study (ROS) (P30AG010161), to accomplish these aims.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia
  • 批准号:
    10608782
  • 项目类别:
  • 资助金额:
    $118.44万
  • 财政年份:
    2021
  • 负责人:
    Konstantinos Arfanakis
  • 依托单位:
Core F: Biomarker/Neuroimaging Core
  • 批准号:
    10472770
  • 项目类别:
  • 资助金额:
    $31.4万
  • 财政年份:
    2021
  • 负责人:
    Konstantinos Arfanakis
  • 依托单位:
Core F: Biomarker/Neuroimaging Core
  • 批准号:
    10264499
  • 项目类别:
  • 资助金额:
    $31.4万
  • 财政年份:
    2021
  • 负责人:
    Konstantinos Arfanakis
  • 依托单位:
Core F: Biomarker/Neuroimaging Core
  • 批准号:
    10669647
  • 项目类别:
  • 资助金额:
    $31.4万
  • 财政年份:
    2021
  • 负责人:
    Konstantinos Arfanakis
  • 依托单位: